Trial intelligence / Profile preview

Menitorix Non-inferiority Study in Toddlers

NCT00326118Phase 3Completed

Sponsor
GSK
Start
Jun 2006
Primary completion
Nov 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Hib-MenC-TT in Haemophilus influenzae type b infection (Hib), meningococcal serogroup C disease, sponsored by GSK. Started Jun 2006; status: completed.

02

Drugs

Hib-MenC-TT
03

Conditions

Haemophilus influenzae type b infection (Hib)meningococcal serogroup C disease

Beyond the preview

Go deeper on NCT00326118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00326118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call